[18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 2, 2009, Pages 209-218

  Dubois, Ludwig ^a,b   Landuyt, Willy ^a   Cloetens, Lieselotte ^a   Bol, Anne ^c   Bormans, Guy ^a   Haustermans, Karin ^a   Labar, Daniel ^c   Nuyts, Johan ^a   Grégoire, Vincent ^c,d   Mortelmans, Luc ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

18F EF3; 18F FMISO; Hypoxia; PET; Tumour

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; 2 (2 NITROIMIDAZOL 1 YL) N (3,3,3 TRIFLUOROPROPYL)ACETAMIDE F 18; TRACER; UNCLASSIFIED DRUG; 1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; 2 (2 NITROIMIDAZOL 1 YL) N (3,3,3 TRIFLUOROPROPYL) ACETAMIDE; 2-(2-NITROIMIDAZOL-1-YL)-N-(3,3,3-TRIFLUOROPROPYL)-ACETAMIDE; BIOLOGICAL MARKER; DIAGNOSTIC AGENT; DRUG DERIVATIVE; MISONIDAZOLE; NITROIMIDAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG STRUCTURE; DRUG UPTAKE; HISTOLOGY; HYPOXIA; IMAGE ANALYSIS; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; RHABDOMYOSARCOMA; STATISTICAL ANALYSIS; TUMOR HYPOXIA; ANIMAL; ANOXIA; COMPARATIVE STUDY; CYTOLOGY; HEART; HEART MUSCLE; METABOLISM; PATHOLOGY; PHYSIOLOGY; REFERENCE VALUE; SCINTISCANNING; TISSUE DISTRIBUTION;

ANIMALS; ANOXIA; AUTORADIOGRAPHY; BIOLOGICAL MARKERS; HEART; MALE; MISONIDAZOLE; MYOCARDIUM; NITROIMIDAZOLES; POSITRON-EMISSION TOMOGRAPHY; RATS; REFERENCE VALUES; RHABDOMYOSARCOMA; TISSUE DISTRIBUTION;

EID: 58849135714     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0907-x     Document Type: Article

References (40)

1. JD Chapman 1984 The detection and measurement of hypoxic cells in solid tumors Cancer 54 2441 9
2. P Vaupel F Kallinowski P Okunieff 1989 Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review Cancer Res 49 6449 65
3. DM Brizel GS Sibley LR Prosnitz RL Scher MW Dewhirst 1997 Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck Int J Radiat Oncol Biol Phys 38 285 9
4. BG Wouters M Koritzinsky RK Chiu J Theys J Buijsen P Lambin 2003 Modulation of cell death in the tumor microenvironment Semin Radiat Oncol 13 31 41
5. MG Magagnin M Koritzinsky BG Wouters 2006 Patterns of tumor oxygenation and their influence on the cellular hypoxic response and hypoxia-directed therapies Drug Resist Updat 9 185 97
6. A Nunn K Linder HW Strauss 1995 Nitroimidazoles and imaging hypoxia Eur J Nucl Med 22 265 80
7. JR Ballinger 2001 Imaging hypoxia in tumors Semin Nucl Med 31 321 9
8. WJ Koh JS Rasey ML Evans JR Grierson TK Lewellen MM Graham 1992 Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole Int J Radiat Oncol Biol Phys 22 199 212
9. 18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia J Nucl Med 40 1072 9
10. P Zanzonico J O'Donoghue JD Chapman R Schneider S Cai S Larson 2004 Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning Eur J Nucl Med Mol Imaging 31 117 28
11. JS Rasey Z Grunbaum S Magee NJ Nelson PL Olive RE Durand 1987 Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells Radiat Res 111 292 304
12. 18F] fluoromisonidazole PET and pO2 electrode measurements. Influence of tumour volume and carbogen breathing Acta Oncol 41 304 12
13. 18F]fluoromisonidazole PET and immunohistochemistry Br J Cancer 91 1947 54
14. 18F]fluoromisonidazole (FMISO) Nucl Med Biol 29 191 7
15. 18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors Radiother Oncol 80 157 64
16. 18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study BMC Cancer 6 51
17. JG Rajendran DL Schwartz J O'Sullivan LM Peterson P Ng J Scharnhorst 2006 Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer Clin Cancer Res 12 5435 41
18. 18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients Radiother Oncol 80 151 6
19. 18F]fluoromisonidazole and pO (2)-polarography in metastatic head and neck cancer Eur J Nucl Med Mol Imaging 33 1426 31
20. 18F]FMISO in an experimental mammary carcinoma Eur J Nucl Med Mol Imaging 31 513 20
21. K Lehtio O Eskola T Viljanen V Oikonen T Gronroos L Sillanmaki 2004 Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer Int J Radiat Oncol Biol Phys 59 971 82
22. 18F-fluoroazomycin arabinoside J Nucl Med 46 106 13
23. 18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors Nucl Med Biol 30 317 26
24. MW Dewhirst 1998 Concepts of oxygen transport at the microcirculatory level Semin Radiat Oncol 8 143 50
25. TM Busch SM Hahn SM Evans CJ Koch 2000 Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide] Cancer Res 60 2636 42
26. CJ Koch 2002 Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5 Methods Enzymol 352 3 31
27. 18F]-labeled EF3 [2-(2-nitroimidazol-1-yl)-N-(3,3,3- trifluoropropyl)-acetamide], a marker for PET detection of hypoxia Bioorg Med Chem 9 665 75
28. 18F]EF3 Eur J Nucl Med Mol Imaging 31 1263 72
29. GW Barendsen JJ Broerse 1969 Experimental radiotherapy of a rat rhabdomyosarcoma with 15 MeV neutrons and 300 kV X-rays. I. Effects of single exposures Eur J Cancer 5 373 91
30. 18F]fluoromisonidazole Appl Radiat Isot 44 1085 91
31. 18F]Fluoro-2-deoxy-D-glucose Acta Oncol 39 629 37
32. 18F]EF3 uptake on an individual mouse tumour basis Eur J Nucl Med Mol Imaging 33 553 6
33. 18F]FETNIM) and PET using the tumour to plasma ratio Eur J Nucl Med Mol Imaging 30 101 8
34. 18F-EF5 Eur J Nucl Med Mol Imaging 30 259 66
35. 18F]EF1 J Nucl Med 41 327 36
36. 18F]EF3: improvement of the tumour-to-background ratio in a mouse tumour model Eur J Nucl Med Mol Imaging 34 1348 54
37. 18F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression Eur J Nucl Med Mol Imaging 30 695 704
38. K Skov H Adomat M Bowden W Dragowska M Gleave CJ Koch 2004 Hypoxia in the androgen-dependent Shionogi model for prostate cancer at three stages Radiat Res 162 547 53
39. P Stadler A Becker HJ Feldmann G Hansgen J Dunst F Wurschmidt 1999 Influence of the hypoxic subvolume on the survival of patients with head and neck cancer Int J Radiat Oncol Biol Phys 44 749 54
40. M Hutchings A Loft M Hansen E Ralfkiaer L Specht 2006 Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake Hematol Oncol 24 146 50